JSA advised and assisted Lupin Limited in acquisition of portfolio of three hundred forty-three (343) brands (including all rights and interests associated with products) from Anglo French Drugs & Industries Limited (“AFDIL”) and its associates.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India offering branded and generic formulations, biotechnology products and active pharmaceutical ingredients. It holds a global leadership position in cardiovascular, anti-diabetic, and respiratory segments and has significant presence in the anti-infective, gastro-intestinal (GI), central nervous system (CNS) and women’s health areas.
AFDIL is in the business of developing, manufacturing, marketing, and distribution of formulation of various drugs in the skin and respiratory segment.
Deal value: INR 325 crore
JSA team comprised Lead Partner – Shivpriya Nanda, Partner – Zain Pandit and Gaurav G. Arora, Associate – Kshitij Gupta.
Gaurav G. Arora is a Partner at JSA with over 12 years of experience advising multinational corporations, investment funds, and high-growth businesses on mergers & acquisitions, private equity investments, corporate structuring, cross-border transactions, foreign direct investment, and general corporate matters. He regularly advises clients on complex domestic and international transactions across the technology, healthcare, manufacturing, real estate, retail, and services sectors. Gaurav is recognised as an ALB India Rising Star and among the Top 10 Young Lawyers by ALB Thomson Reuters.